Sully.ai vs Andson Biotech

Side-by-side comparison of AI visibility scores, market position, and capabilities

Andson Biotech leads in AI visibility (41 vs 34)
Sully.ai logo

Sully.ai

EmergingHealthcare

General

SF healthcare AutonomousOS automating clinical documentation and prior auth for hospitals; YC $30.5M Sequoia Scout/AUM Ventures Series A Jan 2025 competing with Nuance DAX and Abridge for AI-powered physician workflow automation.

AI VisibilityBeta
Overall Score
D34
Category Rank
#558 of 1158
AI Consensus
65%
Trend
up
Per Platform
ChatGPT
44
Perplexity
40
Gemini
34

About

Sully.ai is a San Francisco-based healthcare AI company — backed by Y Combinator with $30.5 to $32.1 million raised including a $21.83 million Series A in January 2025 from AUM Ventures, Leonis Capital, SemperVirens VC, and Sequoia Scout Fund — providing hospitals, physician practices, and health systems with an AutonomousOS platform that automates clinical documentation (ambient AI scribing that generates SOAP notes from patient-physician conversations), administrative workflows (prior authorization processing, insurance eligibility verification, scheduling automation), and revenue cycle management tasks that consume 30-40% of physician time and hospital administrative labor. Founded in 2023 by Ahmed Nasser and Ahmed Omar, Sully.ai has 49 employees and serves healthcare providers globally with AI agents that autonomously execute multi-step clinical and administrative processes without requiring physician or staff intervention.

Full profile
Andson Biotech logo

Andson Biotech

EmergingHealthcare

General

Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.

AI VisibilityBeta
Overall Score
C41
Category Rank
#220 of 1158
AI Consensus
62%
Trend
up
Per Platform
ChatGPT
49
Perplexity
36
Gemini
40

About

Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.

Full profile

AI Visibility Head-to-Head

34
Overall Score
41
#558
Category Rank
#220
65
AI Consensus
62
up
Trend
up
44
ChatGPT
49
40
Perplexity
36
34
Gemini
40
32
Claude
41
30
Grok
51

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.